3D bioprinting has emerged as a promising new approach in the field of tissue engineering and regenerative medicine, enabling the biofabrication of complex biological models and systems. It involves layer-by-layer deposition of bioink (which mimics the extracellular matrix environment and supports cell viability) to create 3D structures, such as tissues and organs.
Traditional 3D bioprinting techniques have many technical and commercial drawbacks (e.g. cell damage, low throughput, high cost, inflexibility). Materic’s novel screen printing technology bypasses all of these challenges. Our approach leverages pattern inks, deposited through screen-supporting patterns onto different surfaces. It has a wide range of applications, from traditional ink printing to printing electronic circuit boards.